Neochem Bio Solutions logo

Neochem Bio Solutions financials: balance sheet, profit and loss, cash flow

NSE: NEOCHEMChemicals & Petrochemicals

Neochem Bio Solutions Limited · Face value ₹10 · Listed Dec 2025 · Issue price ₹98
Last close ₹104.70down ₹3.70 (3.41%)

Share price at the NSE close on 28 Oct 2026. Previous close ₹108.40.

28 Oct: open ₹109.00, high ₹112.75, low ₹104.00

Range of traded prices from listing on 9 Dec 2025 to 28 Oct 2026
₹63.00Low, 30 Mar 2026₹121.00High, 25 May 2026
Market cap
₹179 Cr
P/E
12.19
P/B
2.07
Dividend yield
Nonesince listing in Dec 2025
ROE
17.0%
Debt to equity
0.38
Volume, NSE
25,20076.2% delivered

Neochem Bio Solutions' financial statements for the year to Mar 2026, standalone: the listed company alone, without its subsidiaries, with the half year to Sep 2026 after them.

1 year at a glance

₹ crore, years to March.Neochem Bio Solutions annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
1111218Mar 26

Operating and net margin, per cent

  • Operating margin
  • Net margin
10.9%10.9%10.9%Mar 26

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue111
  2. Depreciation−1.2
  3. Other income+2.7
  4. Finance costs−3.5
  5. Profit before tax17
  6. Tax−5.2
  7. Net profit12

What the company owns

  • Receivables₹49 Cr
  • Plant, investments and other assets₹39 Cr
  • Inventory₹29 Cr
  • Cash and bank₹0 Cr

What pays for it: net worth and liabilities

  • Net worth₹79 Cr
  • Borrowings₹18 Cr
  • Owed to suppliers₹12 Cr
  • Other liabilities₹9 Cr

Profit and loss

Standalone, ₹ crore, years to March. The last column is the twelve months to Sep 2026, the latest two half years added.Neochem Bio Solutions half-yearly results

₹ croreMar 2026Sep 2026Twelve monthsFiled 27 Oct
Revenue from operations111134
––
Materials and goods bought7593
Depreciation and amortisation1–
Other income32
Finance costs43
Profit before one-off items and tax1821
Profit before tax1720
56
Net profit1215
Net margin10.9%11.0%
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2026: revenue, other income and exceptional items less the total expenses stated do not come to the profit before tax the same statement states, so the operating expenses cannot be told apart from the rest.

Balance sheet

Standalone, ₹ crore, at 31 March. The last column is the half year to Sep 2026, after the latest full year: the balance sheet at its end.

₹ croreMar 2026Sep 2026Half yearFiled 27 Oct
7987
Share capital1717
Reserves6270
1833
3655
27
Total assets117149
3144
86105
Net debt1833
Borrowings are counted again inside the liabilities due within a year and after a year. Plant in use and plant being built are given for full years only.

Cash flow

Standalone, ₹ crore, years to March. The last column is the half year to Sep 2026, after the latest full year: the cash flow over its six months.

₹ croreMar 2026Sep 2026Half year
−19.1−1.1
−16.1−0.8
−37.9−13.2
Receivables−23.40.6
Inventories−5.5−11.2
Payables−5.26.2
Other working capital−3.8−8.8
Tax paid−3.00.0
Capital spending2.514.5
Free cash flow−21.6−15.5
−6.5−13.0
25.714.0
Dividends paid0.00.0
Shares issued47.10.0
Net change in cash0.10.0
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2026
Earnings per share₹8.71
Diluted earnings per share₹8.71
Book value per share₹46.05
Shareholder yield−43.5%
Market cap at the year end (₹ crore)108

Ratios

Standalone, years to March.Neochem Bio Solutions PE ratio and valuation

RatioMar 2026
Return on equity15.3%
Cash conversion−158.5%
Debt to equity0.23
Receivable days161
Inventory days143
Payable days56
Cash conversion cycle, days247
Working capital days221
Asset turnover0.95
Assets per rupee of net worth1.49
Sales per rupee of plant5.56
Capital spending to depreciation2.05

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
10.3%

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ croreLatest year
Cash from operations−19.1
Cash from investing−6.5
Cash from financing25.7
Capital spending2.5
Dividends paid0.0
Shares issued for cash47.1
Borrowings raised0.0
Borrowings repaid16.3

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2026
Effective tax ratePublished threshold 17.16 per cent30.01
Tax charged less tax paid, % of profitOur threshold 10 percentage points12.77
A threshold marked as ours has no published figure; it is the line we read the check against.